Sleep Apnea Diagnosis in Children Using Software-generated Apnea-hypopnea Index (AHI) Derived from Data Recorded with a Single Photoplethysmogram Sensor (PPG) : Results from the Childhood Adenotonsillectomy Study (CHAT) Based on Cardiopulmonary...
Overview
Affiliations
Objective: Sleep quality is vital for healthy development in children. Sleep disorders are prevalent and negatively affect sleep quality. Early identification and appropriate intervention can improve children's health and quality of life. The current reference standard, polysomnography (PSG) has limitations regarding availability, cost, and access and may not replicate normal sleep patterns in the home. Simple, accurate sleep tests, available for repeated testing should be beneficial in management of sleep disorders.
Method: Secondary analysis of PSG data from the prospective multicenter Childhood Adenotonsillectomy Trial (CHAT) to evaluate FDA-cleared cloud-based software (Software-as-a-Medical-Device), which is based on analysis of photoplethysmogram data (PPG; plethysmogram-signal (PLETH) and oxygen saturation data (SpO)), to automatically generate a novel apnea-hypopnea index (sAHI). sAHI is compared to manually scored AHI from PSG.
Results: Significant correlation is observed comparing the software-generated sAHI and manually derived AHI from the in-laboratory PSG-studies (Pearson correlation = 0.954, p < 0.0001) and receiver operating characteristics (ROC) demonstrate strong agreement in all OSA categories (mild, moderate, severe) 91.4%[CI89.5, 93.4]; 96.7%[CI95.4, 97.9]; 98.6%[CI97.8, 99.4], sensitivities 95.4%[CI93.2, 97.0]; 86.5%[CI80.3, 91.3]; 88.4%[CI78.4, 94.9] and specificities 84.4%[CI79.7, 88.4]; 99.2%[CI98.2, 99.7]; 99.6%[CI98.8, 99.9], respectively.
Conclusion: sAHI is comparable to manual scoring of AHI from in-laboratory PSG studies and effective to rule-in and rule-out obstructive sleep apnea (OSA) in all disease categories, providing safe and convenient approach for diagnosis and management of OSA in children. The data is recorded with a single-sensor, making the method suitable for multi-night testing in the child's home at considerably lower cost. This technology provides a simple tool to adhere to guidelines for diagnosis and management of OSA in children.
Clinical Trial Registration Name And Number: Childhood Adenotonsillectomy Study for Children with OSA (CHAT) https://clinicaltrials.gov/ct2/show/NCT00560859.
Progress in alternative diagnostic modalities for pediatric obstructive sleep apnea: a global need.
Sanchez-Solano N, Cielo C J Clin Sleep Med. 2024; 21(1):7-8.
PMID: 39484809 PMC: 11701281. DOI: 10.5664/jcsm.11464.
OSA diagnosis goes wearable: are the latest devices ready to shine?.
Chiang A, Jerkins E, Holfinger S, Schutte-Rodin S, Chandrakantan A, Mong L J Clin Sleep Med. 2024; 20(11):1823-1838.
PMID: 39132687 PMC: 11530974. DOI: 10.5664/jcsm.11290.
Hou S, Zhu G, Liu X, Wang C, Liang J, Hao W Front Neurol. 2024; 15:1370609.
PMID: 39114535 PMC: 11303281. DOI: 10.3389/fneur.2024.1370609.
Sleep quality, sleep apnea, and metabolic health in children treated with adenotonsillectomy.
Magnusdottir S, Witmans M, Hilmisson H Sleep Breath. 2022; 27(4):1527-1540.
PMID: 36434376 DOI: 10.1007/s11325-022-02747-3.
Recent advances in paediatric sleep disordered breathing.
Garde A, Gibson N, Samuels M, Evans H Breathe (Sheff). 2022; 18(3):220151.
PMID: 36340818 PMC: 9584598. DOI: 10.1183/20734735.0151-2022.